07:00 , Sep 21, 2015 |  BC Week In Review  |  Clinical News

TxCell preclinical data

In an animal model of non-infectious uveitis, IV Col-Treg significantly inhibited clinical symptoms, retinal tissue lesions and ocular proinflammatory cell infiltration. Data were published in Investigative Ophthalmology & Visual Science. Next year, TxCell plans to...